The acquisition of SiteOne provides a bit of diversification for Lilly, which has burrowed into the obesity and diabetes space with mega-blockbuster tirzepatide and several follow-on molecules.
Lilly Follows Vertex Into Non-Opioid Pain With up to $1B SiteOne Buy Read More »
Federal agencies are seeking public feedback on how to improve price transparency around prescription drugs and boost hospital compliance and enforcement.
Trump administration updates price transparency guidance for hospitals and payers Read More »
The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.
GlycoEra’s lead candidate targets IgG4 autoantibodies, potentially addressing autoimmune diseases such as muscle-specific kinase myasthenia gravis and pemphigus.
Novo-Backed GlycoEra Raises $130M To Advance Protein Degraders for Precision Immunology Read More »
In addition to a $140 million series D, GRIN Therapeutics has signed a global licensing deal for the epilepsy disorder drug radiprodil worth $50 million upfront.
Epilepsy Biotech Nabs up to $570M in Deal With Italy’s Angelini Plus $140M Fundraising Read More »
With $90 million to start, Syndeio has a lead asset in Phase II clinical trials for major depressive disorder, with plans to soon launch a biomarker trial in Alzheimer’s disease.
Acute systemic infection caused the patient to develop fatal capillary leak syndrome, highlighting the unpredictability of gene therapies and potentially challenging investment in the space, analysts say.
Rocket’s Danon Disease Gene Therapy on Hold After Patient Death Read More »
Prothena has already discontinued the development of birtamimab, and anticipates further spending cuts, including workforce reduction.
Prothena Looks at Business Options as Phase III AL Amyloidosis Trial Fails Read More »
According to President Trump, CMS Administrator Mehmet Oz is a “tough hombre” who can bring down drug costs “like a rock.”
Unos especialistas han descubierto y estudiado un extraordinario hallazgo en el yacimiento arqueológico del Abrigo de San Lázaro, en la ciudad española de Segovia. Este descubrimiento constituye el objeto simbólico más antiguo conocido en Europa que contiene una hu …
Encuentran la huella dactilar humana más antigua del mundo Read More »
